Literature DB >> 19590640

Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.

Aram N Demirjian1, Charles M Vollmer, David F McDermott, John T Mullen, Michael B Atkins, Mark P Callery.   

Abstract

BACKGROUND: The pancreas is a rare location for metastatic disease, with only 2-11% of all pancreatic tumours being of non-primary origin. It is also uncommon for renal cell carcinoma (RCC) to metastasize to the pancreas (1-3% of cases) and, when it does, it typically occurs substantially after index nephrectomy. It is not known whether all pancreatic metastases need be resected because today's chemo- and biological therapies are increasingly effective in controlling advanced disease.
METHODS: Six patients with a variety of symptoms are discussed. Four patients presented with recurrent gastrointestinal bleeding, ranging from occult to life-threatening in severity.
RESULTS: The four patients with gastrointestinal bleeding had RCC metastases that had eroded into the duodenum and were successfully controlled by palliative pancreaticoduodenectomy or completion pancreatectomy. The other two patients were treated using different chemotherapeutic or biological agents.
CONCLUSIONS: Renal cell carcinoma metastases to the pancreas typically occur long after index nephrectomy. Although clinical presentation is variable, palliative resection should be reserved for those who develop complications, such as upper gastrointestinal bleeding, and, in other series, obstructive jaundice. Routine debulking resections do not appear to be indicated because current biological therapies effectively and reliably control disease over long periods.

Entities:  

Keywords:  operative palliatively; pancreatic metastases; renal cell carcinoma

Year:  2009        PMID: 19590640      PMCID: PMC2697876          DOI: 10.1111/j.1477-2574.2009.00027.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  18 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

2.  Spontaneous rupture of pancreatic metastasis from renal cell carcinoma.

Authors:  Akitoshi Kobayashi; Taketo Yamaguchi; Takeshi Ishihara; Hiroshi Tadenuma; Kazuyoshi Nakamura; Tadashi Ohshima; Nobuyuki Sakaue; Takeshi Baba; Masaharu Yoshikawa; Hiromitsu Saisho
Journal:  Jpn J Clin Oncol       Date:  2004-11       Impact factor: 3.019

Review 3.  Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery.

Authors:  Franz Sellner; Natascha Tykalsky; Maria De Santis; Jörg Pont; M Klimpfinger
Journal:  Ann Surg Oncol       Date:  2006-01-01       Impact factor: 5.344

4.  Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; M Dror Michaelson; Bruce G Redman; Gary R Hudes; George Wilding; Robert A Figlin; Michelle S Ginsberg; Sindy T Kim; Charles M Baum; Samuel E DePrimo; Jim Z Li; Carlo L Bello; Charles P Theuer; Daniel J George; Brian I Rini
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

5.  Renal cell carcinoma metastatic to the pancreas: clinical and radiological features.

Authors:  R Ghavamian; K A Klein; D H Stephens; T J Welch; A J LeRoy; R L Richardson; P A Burch; H Zincke
Journal:  Mayo Clin Proc       Date:  2000-06       Impact factor: 7.616

6.  Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy.

Authors:  Norifumi Sawada; Mizuya Fukasawa; Isao Araki; Satoru Kira; Kamiyama Manabu; Masayuki Takeda
Journal:  Int J Urol       Date:  2005-11       Impact factor: 3.369

7.  High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma.

Authors:  C Bassi; G Butturini; M Falconi; M Sargenti; W Mantovani; P Pederzoli
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

8.  Pancreatic resection for metastatic renal cell carcinoma to the pancreas.

Authors:  Kamran M H Karimi; David W McFadden
Journal:  Am Surg       Date:  2007-11       Impact factor: 0.688

9.  Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?

Authors:  Alessandro Zerbi; Enrico Ortolano; Gianpaolo Balzano; Anna Borri; Aldo Alberto Beneduce; Valerio Di Carlo
Journal:  Ann Surg Oncol       Date:  2008-01-15       Impact factor: 5.344

Review 10.  Targeted therapy for metastatic renal cell carcinoma.

Authors:  P H Patel; R S K Chaganti; R J Motzer
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  2 in total

1.  Unexpected Prolonged Survival After Extended and Emergent Resection of Pancreatic Metastases from Renal Cell Carcinoma.

Authors:  Stefania Brozzetti; Antonio V Sterpetti
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Results of surgical management of renal cell carcinoma metastatic to the pancreas.

Authors:  Katarzyna Kusnierz; Slawomir Mrowiec; Pawel Lampe
Journal:  Contemp Oncol (Pozn)       Date:  2014-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.